The antidiabetic potential of quercetin: Underlying mechanisms

Current Medicinal Chemistry

Volumn 24, Issue 4, 2017, Pages 355-364

  Eid, Hoda M ^a,b,c   Haddad, Pierre S ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CANADIAN INSTITUTES OF HEALTH RESEARCH   (Canada)

^c BENI SUEF UNIVERSITY   (Egypt)

Author keywords

Flavonoids; Glucolipotoxicity; Gluconeogenesis; Glucose absorption; Glucose uptake; Insulin resistance; Insulin secretion. AMPK

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; INSULIN; QUERCETIN;

ADIPOSE TISSUE; ANTIDIABETIC ACTIVITY; DIABETES MELLITUS; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG MECHANISM; GLUCOSE ABSORPTION; GLUCOSE HOMEOSTASIS; GLUCOSE UTILIZATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTESTINE ABSORPTION; LIVER; NONHUMAN; PANCREAS; PLEIOTROPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SKELETAL MUSCLE; SMALL INTESTINE; ANIMAL;

ANIMALS; HUMANS; HYPOGLYCEMIC AGENTS; QUERCETIN;

EID: 85015427064     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867323666160909153707     Document Type: Review

References (99)

1. WHO Diabetes Fact sheet No. 312. Available at: http://www.who.int/ mediacentre/factsheets/fs312/en/.
2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care, 2009, 32(Suppl. 1), S62-S67.
3. Pandey, K.B.; Rizvi, S.I. Plant polyphenols as dietary antioxidants in human health and disease. Oxid. Med. Cell. Longev., 2009, 2(5), 270-278.
4. Chaudhuri, S.; Sengupta, B.; Taylor, J.; Pahari, B.P.; Sengupta, P.K. Interactions of dietary flavonoids with proteins: insights from fluorescence spectroscopy and other related biophysical studies. Curr. Drug Metab., 2013, 14(4), 491-503.
5. Kumar, S.; Pandey, A.K. Chemistry and biological activities of flavonoids: an overview. Sci. World J., 2013, 2013, 162750.
6. Day, A.J.; Canada, F.J.; Diaz, J.C.; Kroon, P.A.; Mclauchlan, R.; Faulds, C.B.; Plumb, G.W.; Morgan, M.R.; Williamson, G. Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett., 2000, 468(2-3), 166-170.
7. Amaretti, A.; Raimondi, S.; Leonardi, A.; Quartieri, A.; Rossi, M. Hydrolysis of the rutinose-conjugates flavonoids rutin and hesperidin by the gut microbiota and bifidobacteria. Nutrients, 2015, 7(4), 2788-2800.
8. Walle, T.; Browning, A.M.; Steed, L.L.; Reed, S.G.; Walle, U.K. Flavonoid glucosides are hydrolyzed and thus activated in the oral cavity in humans. J. Nutr., 2005, 135(1), 48-52.
9. Djuric, Z.; Severson, R.K.; Kato, I. Association of dietary quercetin with reduced risk of proximal colon cancer. Nutr. Cancer, 2012, 64(3), 351-360.
10. Manach, C.; Scalbert, A.; Morand, C.; Remesy, C.; Jimenez, L. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr., 2004, 79(5), 727-747.
11. Formica, J.V.; Regelson, W. Review of the biology of Quercetin and related bioflavonoids. Food Chem. Toxicol., 1995, 33(12), 1061-1080.
12. Egert, S.; Wolffram, S.; Bosy-Westphal, A.; Boesch-Saadatmandi, C.; Wagner, A.E.; Frank, J.; Rimbach, G.; Mueller, M.J. Daily quercetin supplementation dosedependently increases plasma quercetin concentrations in healthy humans. J. Nutr., 2008, 138(9), 1615-1621.
13. D'Andrea, G. Quercetin: A flavonol with multifaceted therapeutic applications? Fitoterapia, 2015, 106, 256-271.
14. Walle, T.; Otake, Y.; Walle, U.K.; Wilson, F.A. Quercetin glucosides are completely hydrolyzed in ileostomy patients before absorption. J. Nutr., 2000, 130(11), 2658-2661.
15. Aziz, A.A.; Edwards, C.A.; Lean, M.E.; Crozier, A. Absorption and excretion of conjugated flavonols, including quercetin-4′-O-beta-glucoside and isorhamnetin-4′-O-betaglucoside by human volunteers after the consumption of onions. Free Radic. Res., 1998, 29(3), 257-269.
16. Gugler, R.; Leschik, M.; Dengler, H.J. Disposition of quercetin in man after single oral and intravenous doses. Eur. J. Clin. Pharmacol., 1975, 9(2-3), 229-234.
17. Meng, X.; Maliakal, P.; Lu, H.; Lee, M.J.; Yang, C.S. Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice. J. Agric. Food Chem., 2004, 52(4), 935-942.
18. Egert, S.; Bosy-Westphal, A.; Seiberl, J.; Kurbitz, C.; Settler, U.; Plachta-Danielzik, S.; Wagner, A.E.; Frank, J.; Schrezenmeir, J.; Rimbach, G.; Wolffram, S.; Muller, M.J. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br. J. Nutr., 2009, 102(7), 1065-1074.
19. Jin, F.; Nieman, D.C.; Shanely, R.A.; Knab, A.M.; Austin, M.D.; Sha, W. The variable plasma quercetin response to 12-week quercetin supplementation in humans. Eur. J. Clin. Nutr., 2010, 64(7), 692-697.
20. Erlund, I.; Freese, R.; Marniemi, J.; Hakala, P.; Alfthan, G. Bioavailability of quercetin from berries and the diet. Nutr. Cancer, 2006, 54(1), 13-17.
21. Erlund, I.; Marniemi, J.; Hakala, P.; Alfthan, G.; Meririnne, E.; Aro, A. Consumption of black currants, lingonberries and bilberries increases serum quercetin concentrations. Eur. J. Clin. Nutr., 2003, 57(1), 37-42.
22. McAnlis, G.T.; McEneny, J.; Pearce, J.; Young, I.S. Absorption and antioxidant effects of quercetin from onions, in man. Eur. J. Clin. Nutr., 1999, 53(2), 92-96.
23. Kyle, J.A.; Morrice, P.C.; McNeill, G.; Duthie, G.G. Effects of infusion time and addition of milk on content and absorption of polyphenols from black tea. J. Agric. Food Chem., 2007, 55(12), 4889-4894.
24. Davalos, A.; Castilla, P.; Gomez-Cordoves, C.; Bartolome, B. Quercetin is bioavailable from a single ingestion of grape juice. Int. J. Food Sci. Nutr., 2006, 57(5-6), 391-398.
25. Hollman, P.C.; van Trijp, J.M.; Buysman, M.N.; van der Gaag, M.S.; Mengelers, M.J.; de Vries, J.H.; Katan, M.B. Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett., 1997, 418(1-2), 152-156.
26. Grau, M.J.; Kayser, O.; Muller, R.H. Nanosuspensions of poorly soluble drugs-reproducibility of small scale production. Int. J. Pharm., 2000, 196(2), 155-159.
27. Merisko-Liversidge, E.; Liversidge, G.G.; Cooper, E.R. Nanosizing: a formulation approach for poorly-watersoluble compounds. Eur. J. Pharm. Sci., 2003, 18(2), 113-120.
28. Kumari, A.; Yadav, S.K.; Pakade, Y.B.; Singh, B.; Yadav, S.C. Development of biodegradable nanoparticles for delivery of quercetin. Colloids Surf. B Biointerfaces, 2010, 80(2), 184-192.
29. Aytac, Z.; Kusku, S.I.; Durgun, E.; Uyar, T. Quercetin/betacyclodextrin inclusion complex embedded nanofibres: Slow release and high solubility. Food Chem., 2016, 197(Pt A), 864-871.
30. Caddeo, C.; Diez-Sales, O.; Pons, R.; Carbone, C.; Ennas, G.; Puglisi, G.; Fadda, A.M.; Manconi, M. Cross-linked chitosan/liposome hybrid system for the intestinal delivery of quercetin. J. Colloid Interface Sci., 2016, 461, 69-78.
31. Wang, H.; Cui, Y.; Fu, Q.; Deng, B.; Li, G.; Yang, J.; Wu, T.; Xie, Y. A phospholipid complex to improve the oral bioavailability of flavonoids. Drug Dev. Ind. Pharm., 2015, 41(10), 1693-1703.
32. Kim, M.K.; Park, K.S.; Yeo, W.S.; Choo, H.; Chong, Y. In vitro solubility, stability and permeability of novel quercetin-amino acid conjugates. Bioorg. Med. Chem., 2009, 17(3), 1164-1171.
33. Dian, L.; Yu, E.; Chen, X.; Wen, X.; Zhang, Z.; Qin, L.; Wang, Q.; Li, G.; Wu, C. Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles. Nanoscale Res. Lett., 2014, 9(1), 2406.
34. de Boer, V.C.; Dihal, A.A.; van der Woude, H.; Arts, I.C.; Wolffram, S.; Alink, G.M.; Rietjens, I.M.; Keijer, J.; Hollman, P.C. Tissue distribution of quercetin in rats and pigs. J. Nutr., 2005, 135(7), 1718-1725.
35. Menendez, C.; Duenas, M.; Galindo, P.; Gonzalez-Manzano, S.; Jimenez, R.; Moreno, L.; Zarzuelo, M.J.; Rodriguez-Gomez, I.; Duarte, J.; Santos-Buelga, C.; Perez-Vizcaino, F. Vascular deconjugation of quercetin glucuronide: the flavonoid paradox revealed? Mol. Nutr. Food Res., 2011, 55(12), 1780-1790.
36. Beekmann, K.; Actis-Goretta, L.; van Bladeren, P.J.; Dionisi, F.; Destaillats, F.; Rietjens, I.M. A state-of-the-art overview of the effect of metabolic conjugation on the biological activity of flavonoids. Food Funct., 2012, 3(10), 1008-1018.
37. Mithieux, G. The new functions of the gut in the control of glucose homeostasis. Curr. Opin. Clin. Nutr. Metab. Care, 2005, 8(4), 445-449.
38. Ait-Omar, A.; Monteiro-Sepulveda, M.; Poitou, C.; Le Gall, M.; Cotillard, A.; Gilet, J.; Garbin, K.; Houllier, A.; Chateau, D.; Lacombe, A.; Veyrie, N.; Hugol, D.; Tordjman, J.; Magnan, C.; Serradas, P.; Clement, K.; Leturque, A.; Brot-Laroche, E. GLUT2 accumulation in enterocyte apical and intracellular membranes: a study in morbidly obese human subjects and ob/ob and high fat-fed mice. Diabetes, 2011, 60(10), 2598-2607.
39. Dyer, J.; Wood, I.S.; Palejwala, A.; Ellis, A.; Shirazi-Beechey, S.P. Expression of monosaccharide transporters in intestine of diabetic humans. Am. J. Physiol. Gastrointest. Liver Physiol., 2002, 282(2), G241-G248.
40. Kwon, O.; Eck, P.; Chen, S.; Corpe, C.P.; Lee, J.H.; Kruhlak, M.; Levine, M. Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. FASEB J., 2007, 21(2), 366-377.
41. Lee, Y.; Lim, Y.; Kwon, O. Selected phytochemicals and culinary plant extracts inhibit fructose uptake in caco-2 cells. Molecules, 2015, 20(9), 17393-17404.
42. Song, J.; Kwon, O.; Chen, S.; Daruwala, R.; Eck, P.; Park, J.B.; Levine, M. Flavonoid inhibition of sodium-dependent vitamin C transporter 1 (SVCT1) and glucose transporter isoform 2 (GLUT2), intestinal transporters for vitamin C and Glucose. J. Biol. Chem., 2002, 277(18), 15252-15260.
43. Cermak, R.; Landgraf, S.; Wolffram, S. Quercetin glucosides inhibit glucose uptake into brush-border-membrane vesicles of porcine jejunum. Br. J. Nutr., 2004, 91(6), 849-855.
44. Ader, P.; Block, M.; Pietzsch, S.; Wolffram, S. Interaction of quercetin glucosides with the intestinal sodium/glucose co-transporter (SGLT-1). Cancer Lett., 2001, 162(2), 175-180.
45. Wong, J.M.; Jenkins, D.J. Carbohydrate digestibility and metabolic effects. J. Nutr., 2007, 137(11)(Suppl.), 2539S-2546S.
46. Figueiredo-Gonzalez, M.; Grosso, C.; Valentao, P.; Andrade, P.B. α-Glucosidase and α-amylase inhibitors from Myrcia spp.: a stronger alternative to acarbose? J. Pharm. Biomed. Anal., 2016, 118, 322-327.
47. Ishikawa, A.; Yamashita, H.; Hiemori, M.; Inagaki, E.; Kimoto, M.; Okamoto, M.; Tsuji, H.; Memon, A.N.; Mohammadio, A.; Natori, Y. Characterization of inhibitors of postprandial hyperglycemia from the leaves of Nerium indicum. J. Nutr. Sci. Vitaminol. (Tokyo), 2007, 53(2), 166-173.
48. Aderogba, M.A.; Ndhlala, A.R.; Rengasamy, K.R.; Van Staden, J. Antimicrobial and selected in vitro enzyme inhibitory effects of leaf extracts, flavonols and indole alkaloids isolated from Croton menyharthii. Molecules, 2013, 18(10), 12633-12644.
49. Jhong, C.H.; Riyaphan, J.; Lin, S.H.; Chia, Y.C.; Weng, C.F. Screening alpha-glucosidase and alpha-amylase inhibitors from natural compounds by molecular docking in silico. Biofactors, 2015, 41(4), 242-251.
50. Jo, S.H.; Ka, E.H.; Lee, H.S.; Apostolidis, E.; Jang, H.D.; Kwon, Y.I. Comparison of antioxidant potential and rat intestinal α-glucosidases inhibitory activities of quercetin, rutin, and isoquercetin. Int. J. Appl. Res. Nat. Prod., 2010, 2(4), 52-60.
51. Kumar, S.; Kumar, V.; Prakash, O. Enzymes inhibition and antidiabetic effect of isolated constituents from Dillenia indica. BioMed. Res. Int., 2013, 2013, 382063.
52. Na, B.; Nguyen, P.H.; Zhao, B.T.; Vo, Q.H.; Min, B.S.; Woo, M.H. Protein tyrosine phosphatase 1B (PTP1B) inhibitory activity and glucosidase inhibitory activity of compounds isolated from Agrimonia pilosa. Pharm. Biol., 2016, 54(3), 474-480.
53. Nickavar, B.; Amin, G. Enzyme assay guided isolation of an α-amylase inhibitor flavonoid from Vaccinium arctostaphylos leaves. Iran. J. Pharm. Res., 2011, 10(4), 849-853.
54. Tadera, K.; Minami, Y.; Takamatsu, K.; Matsuoka, T. Inhibition of alpha-glucosidase and alpha-amylase by flavonoids. J. Nutr. Sci. Vitaminol. (Tokyo), 2006, 52(2), 149-153.
55. Robertson, R.P.; Harmon, J.; Tran, P.O.; Tanaka, Y.; Takahashi, H. Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes, 2003, 52(3), 581-587.
56. Kim, J.W.; Yoon, K.H. Glucolipotoxicity in pancreatic beta-cells. Diabetes Metab. J., 2011, 35(5), 444-450.
57. Poitout, V.; Robertson, R.P. Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr. Rev., 2008, 29(3), 351-366.
58. Gonzalez-Abuin, N.; Pinent, M.; Casanova-Marti, A.; Arola, L.; Blay, M.; Ardevol, A. Procyanidins and their healthy protective effects against type 2 diabetes. Curr. Med. Chem., 2015, 22(1), 39-50.
59. Tanaka, Y.; Gleason, C.E.; Tran, P.O.; Harmon, J.S.; Robertson, R.P. Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc. Natl. Acad. Sci. USA, 1999, 96(19), 10857-10862.
60. Kaneto, H.; Kajimoto, Y.; Miyagawa, J.; Matsuoka, T.; Fujitani, Y.; Umayahara, Y.; Hanafusa, T.; Matsuzawa, Y.; Yamasaki, Y.; Hori, M. Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes, 1999, 48(12), 2398-2406.
61. Tang, C.; Han, P.; Oprescu, A.I.; Lee, S.C.; Gyulkhandanyan, A.V.; Chan, G.N.; Wheeler, M.B.; Giacca, A. Evidence for a role of superoxide generation in glucoseinduced beta-cell dysfunction in vivo. Diabetes, 2007, 56(11), 2722-2731.
62. Youl, E.; Bardy, G.; Magous, R.; Cros, G.; Sejalon, F.; Virsolvy, A.; Richard, S.; Quignard, J.F.; Gross, R.; Petit, P.; Bataille, D.; Oiry, C. Quercetin potentiates insulin secretion and protects INS-1 pancreatic β-cells against oxidative damage via the ERK1/2 pathway. Br. J. Pharmacol., 2010, 161(4), 799-814.
63. Dai, X.; Ding, Y.; Zhang, Z.; Cai, X.; Li, Y. Quercetin and quercitrin protect against cytokine-induced injuries in RINm5F β-cells via the mitochondrial pathway and NF-κB signaling. Int. J. Mol. Med., 2013, 31(1), 265-271.
64. Youl, E.; Magous, R.; Cros, G.; Oiry, C. MAP Kinase cross talks in oxidative stress-induced impairment of insulin secretion. Involvement in the protective activity of quercetin. Fundam. Clin. Pharmacol., 2014, 28(6), 608-615.
65. Adewole, S.O.; Caxton-Martins, E.A.; Ojewole, J.A. Protective effect of quercetin on the morphology of pancreatic beta-cells of streptozotocin-treated diabetic rats. Afr. J. Tradit. Complement. Altern. Med., 2006, 4(1), 64-74.
66. Eckel, R.H.; Kahn, S.E.; Ferrannini, E.; Goldfine, A.B.; Nathan, D.M.; Schwartz, M.W.; Smith, R.J.; Smith, S.R. Obesity and type 2 diabetes: what can be unified and what needs to be individualized? J. Clin. Endocrinol. Metab., 2011, 96(6), 1654-1663.
67. Eid, H.M.; Martineau, L.C.; Saleem, A.; Muhammad, A.; Vallerand, D.; Benhaddou-Andaloussi, A.; Nistor, L.; Afshar, A.; Arnason, J.T.; Haddad, P.S. Stimulation of AMPactivated protein kinase and enhancement of basal glucose uptake in muscle cells by quercetin and quercetin glycosides, active principles of the antidiabetic medicinal plant Vaccinium vitis-idaea. Mol. Nutr. Food Res., 2010, 54(7), 991-1003.
68. Eid, H.M.; Nachar, A.; Thong, F.; Sweeney, G.; Haddad, P.S. The molecular basis of the antidiabetic action of quercetin in cultured skeletal muscle cells and hepatocytes. Pharmacogn. Mag., 2015, 11(41), 74-81.
69. Olson, A.L. Regulation of GLUT4 and insulin-dependent glucose flux. ISRN Mol. Biol., 2012, 2012, 12.
70. Anhe, G.F.; Okamoto, M.M.; Kinote, A.; Sollon, C.; Lellis-Santos, C.; Anhe, F.F.; Lima, G.A.; Hirabara, S.M.; Velloso, L.A.; Bordin, S.; Machado, U.F. Quercetin decreases inflammatory response and increases insulin action in skeletal muscle of ob/ob mice and in L6 myotubes. Eur. J. Pharmacol., 2012, 689(1-3), 285-293.
71. Fang, X.K.; Gao, J.; Zhu, D.N. Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity. Life Sci., 2008, 82(11-12), 615-622.
72. Eid, H.M.; Ouchfoun, M.; Saleem, A.; Guerrero-Analco, J.A.; Walshe-Roussel, B.; Musallam, L.; Rapinski, M.; Cuerrier, A.; Martineau, L.C.; Arnason, J.T.; Haddad, P.S. A combination of (+)-catechin and (-)-epicatechin underlies the in vitro adipogenic action of Labrador tea (Rhododendron groenlandicum), an antidiabetic medicinal plant of the Eastern James Bay Cree pharmacopeia. J. Ethnopharmacol., 2016, 178, 251-257.
73. Ahn, J.; Lee, H.; Kim, S.; Park, J.; Ha, T. The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochem. Biophys. Res. Commun., 2008, 373(4), 545-549.
74. Strobel, P.; Allard, C.; Perez-Acle, T.; Calderon, R.; Aldunate, R.; Leighton, F. Myricetin, quercetin and catechingallate inhibit glucose uptake in isolated rat adipocytes. Biochem. J., 2005, 386(Pt 3), 471-478.
75. Xu, M.; Hu, J.; Zhao, W.; Gao, X.; Jiang, C.; Liu, K.; Liu, B.; Huang, F. Quercetin differently regulates insulinmediated glucose transporter 4 translocation under basal and inflammatory conditions in adipocytes. Mol. Nutr. Food Res., 2014, 58(5), 931-941.
76. Rojas, L.B.; Gomes, M.B. Metformin: an old but still the best treatment for type 2 diabetes. Diabetol. Metab. Syndr., 2013, 5(1), 6.
77. Guigas, B.; Bertrand, L.; Taleux, N.; Foretz, M.; Wiernsperger, N.; Vertommen, D.; Andreelli, F.; Viollet, B.; Hue, L. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation. Diabetes, 2006, 55(4), 865-874.
78. Mithieux, G.; Guignot, L.; Bordet, J.C.; Wiernsperger, N. Intrahepatic mechanisms underlying the effect of metformin in decreasing basal glucose production in rats fed a high-fat diet. Diabetes, 2002, 51(1), 139-143.
79. Gasparin, F.R.; Spitzner, F.L.; Ishii-Iwamoto, E.L.; Bracht, A.; Constantin, J. Actions of quercetin on gluconeogenesis and glycolysis in rat liver. Xenobiotica, 2003, 33(9), 903-911.
80. Gasparin, F.R.; Salgueiro-Pagadigorria, C.L.; Bracht, L.; Ishii-Iwamoto, E.L.; Bracht, A.; Constantin, J. Action of quercetin on glycogen catabolism in the rat liver. Xenobiotica, 2003, 33(6), 587-602.
81. Gonzalez-Mujica, F.; Motta, N.; Estrada, O.; Perdomo, E.; Mendez, J.; Hasegawa, M. Inhibition of hepatic neoglucogenesis and glucose-6-phosphatase by quercetin 3-Oalpha( 2″-galloyl)rhamnoside isolated from Bauhinia megalandra leaves. Phytother. Res., 2005, 19(7), 624-627.
82. Vessal, M.; Hemmati, M.; Vasei, M. Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp. Biochem. Physiol. C Toxicol. Pharmacol., 2003, 135C(3), 357-364.
83. Liu, L.; Gao, C.; Yao, P.; Gong, Z. Quercetin alleviates high-fat diet-induced oxidized low-density lipoprotein accumulation in the liver: implication for autophagy regulation. BioMed Res. Int., 2015, 2015, 9.
84. Hoek-van den Hil, E.F.; van Schothorst, E.M.; van der Stelt, I.; Swarts, H.J.; Venema, D.; Sailer, M.; Vervoort, J.J.; Hollman, P.C.; Rietjens, I.M.; Keijer, J. Quercetin decreases high-fat diet induced body weight gain and accumulation of hepatic and circulating lipids in mice. Genes Nutr., 2014, 9(5), 418.
85. Jung, C.H.; Cho, I.; Ahn, J.; Jeon, T.I.; Ha, T.Y. Quercetin reduces high-fat diet-induced fat accumulation in the liver by regulating lipid metabolism genes. Phytother. Res., 2013, 27(1), 139-143.
86. Kobori, M.; Masumoto, S.; Akimoto, Y.; Oike, H. Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6J mice. Mol. Nutr. Food Res., 2011, 55(4), 530-540.
87. Kobori, M.; Masumoto, S.; Akimoto, Y.; Takahashi, Y. Dietary quercetin alleviates diabetic symptoms and reduces streptozotocin-induced disturbance of hepatic gene expression in mice. Mol. Nutr. Food Res., 2009, 53(7), 859-868.
88. Rivera, L.; Moron, R.; Sanchez, M.; Zarzuelo, A.; Galisteo, M. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity (Silver Spring), 2008, 16(9), 2081-2087.
89. Kannappan, S.; Anuradha, C.V. Insulin sensitizing actions of fenugreek seed polyphenols, quercetin & metformin in a rat model. Indian J. Med. Res., 2009, 129(4), 401-408.
90. Wein, S.; Behm, N.; Petersen, R.K.; Kristiansen, K.; Wolffram, S. Quercetin enhances adiponectin secretion by a PPAR-gamma independent mechanism. Eur. J. Pharm. Sci., 2010, 41(1), 16-22.
91. Koch, C.E.; Ganjam, G.K.; Steger, J.; Legler, K.; Stohr, S.; Schumacher, D.; Hoggard, N.; Heldmaier, G.; Tups, A. The dietary flavonoids naringenin and quercetin acutely impair glucose metabolism in rodents possibly via inhibition of hypothalamic insulin signalling. Br. J. Nutr., 2013, 109(6), 1040-1051.
92. Romero, M.; Jimenez, R.; Hurtado, B.; Moreno, J.M.; Rodriguez-Gomez, I.; Lopez-Sepulveda, R.; Zarzuelo, A.; Perez-Vizcaino, F.; Tamargo, J.; Vargas, F.; Duarte, J. Lack of beneficial metabolic effects of quercetin in adult spontaneously hypertensive rats. Eur. J. Pharmacol., 2010, 627(1-3), 242-250.
93. Valensi, P.; Le Devehat, C.; Richard, J.L.; Farez, C.; Khodabandehlou, T.; Rosenbloom, R.A.; LeFante, C. A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report. J. Diabetes Compl., 2005, 19(5), 247-253.
94. Broman-Fulks, J.J.; Canu, W.H.; Trout, K.L.; Nieman, D.C. The effects of quercetin supplementation on cognitive functioning in a community sample: a randomized, placebocontrolled trial. Ther. Adv. Psychopharmacol., 2012, 2(4), 131-138.
95. Shanely, R.A.; Knab, A.M.; Nieman, D.C.; Jin, F.; McAnulty, S.R.; Landram, M.J. Quercetin supplementation does not alter antioxidant status in humans. Free Radic. Res., 2010, 44(2), 224-231.
96. Brull, V.; Burak, C.; Stoffel-Wagner, B.; Wolffram, S.; Nickenig, G.; Muller, C.; Langguth, P.; Alteheld, B.; Fimmers, R.; Naaf, S.; Zimmermann, B.F.; Stehle, P.; Egert, S. Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: a randomised double-blinded placebo-controlled cross-over trial. Br. J. Nutr., 2015, 114(8), 1263-1277.
97. Murota, K.; Terao, J. Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch. Biochem. Biophys., 2003, 417(1), 12-17.
98. Kay, C.D. The future of flavonoid research. Br. J. Nutr., 2010, 104(3), S91-S95.
99. Marin, L.; Miguelez, E.M.; Villar, C.J.; Lombo, F. Bioavailability of dietary polyphenols and gut microbiota metabolism: antimicrobial properties. BioMed. Res. Int., 2015, 2015, 905215.